A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase

Toyoshi Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonta, H. Utsumi, H. Sumimoto, H. Y. Yu, N. Sonoda, M. Inuo, N. Sato, N. Sekiguchi, K. Kobayashi, H. Nawata

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

A growing body of evidence has shown that oxidative stress may be involved in the development of vascular complications associated with diabetes. However, the molecular mechanism for increased reactive oxygen species (ROS) production in diabetes remains uncertain. Among various possible mechanisms, attention have increasingly been paid to NAD(P)H oxidase as the most important source of ROS production in vascular cells. High glucose level stimulates ROS production through protein kinase C (PKC)-dependent activation of vascular NAD(P)H oxidase. Furthermore, the expression of NAD(P)H oxidase components is increased in micro- and macrovascular tissues of diabetic animals in association with various functional disorders and histochemical abnormalities. These results suggest that vascular NAD(P)H oxidase-driven ROS production may contribute to the onset or development of diabetic micro- or macrovascular complications. In this point of view, the possible new strategy of antioxidative therapy for diabetic vascular complications is discussed in this review.

Original languageEnglish
Pages (from-to)1759-1764
Number of pages6
JournalCurrent Medicinal Chemistry
Volume10
Issue number17
DOIs
Publication statusPublished - Sep 5 2003

Fingerprint

Diabetic Angiopathies
NADPH Oxidase
Blood Vessels
Reactive Oxygen Species
Medical problems
Oxidative stress
Therapeutics
Protein Kinase C
Animals
Oxidative Stress
Chemical activation
Association reactions
Tissue
Glucose

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Inoguchi, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonta, T., Utsumi, H., ... Nawata, H. (2003). A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase. Current Medicinal Chemistry, 10(17), 1759-1764. https://doi.org/10.2174/0929867033457133

A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase. / Inoguchi, Toyoshi; Tsubouchi, H.; Etoh, T.; Kakimoto, M.; Sonta, T.; Utsumi, H.; Sumimoto, H.; Yu, H. Y.; Sonoda, N.; Inuo, M.; Sato, N.; Sekiguchi, N.; Kobayashi, K.; Nawata, H.

In: Current Medicinal Chemistry, Vol. 10, No. 17, 05.09.2003, p. 1759-1764.

Research output: Contribution to journalReview article

Inoguchi, T, Tsubouchi, H, Etoh, T, Kakimoto, M, Sonta, T, Utsumi, H, Sumimoto, H, Yu, HY, Sonoda, N, Inuo, M, Sato, N, Sekiguchi, N, Kobayashi, K & Nawata, H 2003, 'A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase', Current Medicinal Chemistry, vol. 10, no. 17, pp. 1759-1764. https://doi.org/10.2174/0929867033457133
Inoguchi, Toyoshi ; Tsubouchi, H. ; Etoh, T. ; Kakimoto, M. ; Sonta, T. ; Utsumi, H. ; Sumimoto, H. ; Yu, H. Y. ; Sonoda, N. ; Inuo, M. ; Sato, N. ; Sekiguchi, N. ; Kobayashi, K. ; Nawata, H. / A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase. In: Current Medicinal Chemistry. 2003 ; Vol. 10, No. 17. pp. 1759-1764.
@article{1808e6cf5530417e9ac6532f66e9c08d,
title = "A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase",
abstract = "A growing body of evidence has shown that oxidative stress may be involved in the development of vascular complications associated with diabetes. However, the molecular mechanism for increased reactive oxygen species (ROS) production in diabetes remains uncertain. Among various possible mechanisms, attention have increasingly been paid to NAD(P)H oxidase as the most important source of ROS production in vascular cells. High glucose level stimulates ROS production through protein kinase C (PKC)-dependent activation of vascular NAD(P)H oxidase. Furthermore, the expression of NAD(P)H oxidase components is increased in micro- and macrovascular tissues of diabetic animals in association with various functional disorders and histochemical abnormalities. These results suggest that vascular NAD(P)H oxidase-driven ROS production may contribute to the onset or development of diabetic micro- or macrovascular complications. In this point of view, the possible new strategy of antioxidative therapy for diabetic vascular complications is discussed in this review.",
author = "Toyoshi Inoguchi and H. Tsubouchi and T. Etoh and M. Kakimoto and T. Sonta and H. Utsumi and H. Sumimoto and Yu, {H. Y.} and N. Sonoda and M. Inuo and N. Sato and N. Sekiguchi and K. Kobayashi and H. Nawata",
year = "2003",
month = "9",
day = "5",
doi = "10.2174/0929867033457133",
language = "English",
volume = "10",
pages = "1759--1764",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "17",

}

TY - JOUR

T1 - A possible target of antioxidative therapy for diabetic vascular complications-vascular NAD(P)H oxidase

AU - Inoguchi, Toyoshi

AU - Tsubouchi, H.

AU - Etoh, T.

AU - Kakimoto, M.

AU - Sonta, T.

AU - Utsumi, H.

AU - Sumimoto, H.

AU - Yu, H. Y.

AU - Sonoda, N.

AU - Inuo, M.

AU - Sato, N.

AU - Sekiguchi, N.

AU - Kobayashi, K.

AU - Nawata, H.

PY - 2003/9/5

Y1 - 2003/9/5

N2 - A growing body of evidence has shown that oxidative stress may be involved in the development of vascular complications associated with diabetes. However, the molecular mechanism for increased reactive oxygen species (ROS) production in diabetes remains uncertain. Among various possible mechanisms, attention have increasingly been paid to NAD(P)H oxidase as the most important source of ROS production in vascular cells. High glucose level stimulates ROS production through protein kinase C (PKC)-dependent activation of vascular NAD(P)H oxidase. Furthermore, the expression of NAD(P)H oxidase components is increased in micro- and macrovascular tissues of diabetic animals in association with various functional disorders and histochemical abnormalities. These results suggest that vascular NAD(P)H oxidase-driven ROS production may contribute to the onset or development of diabetic micro- or macrovascular complications. In this point of view, the possible new strategy of antioxidative therapy for diabetic vascular complications is discussed in this review.

AB - A growing body of evidence has shown that oxidative stress may be involved in the development of vascular complications associated with diabetes. However, the molecular mechanism for increased reactive oxygen species (ROS) production in diabetes remains uncertain. Among various possible mechanisms, attention have increasingly been paid to NAD(P)H oxidase as the most important source of ROS production in vascular cells. High glucose level stimulates ROS production through protein kinase C (PKC)-dependent activation of vascular NAD(P)H oxidase. Furthermore, the expression of NAD(P)H oxidase components is increased in micro- and macrovascular tissues of diabetic animals in association with various functional disorders and histochemical abnormalities. These results suggest that vascular NAD(P)H oxidase-driven ROS production may contribute to the onset or development of diabetic micro- or macrovascular complications. In this point of view, the possible new strategy of antioxidative therapy for diabetic vascular complications is discussed in this review.

UR - http://www.scopus.com/inward/record.url?scp=10744220595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744220595&partnerID=8YFLogxK

U2 - 10.2174/0929867033457133

DO - 10.2174/0929867033457133

M3 - Review article

C2 - 12871120

AN - SCOPUS:10744220595

VL - 10

SP - 1759

EP - 1764

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 17

ER -